Back to News
Market Impact: 0.2
AVITA Medical Consensus Price Target Increased 10.81% to $13.94
Source: Nasdaq
Analyst InsightsAnalyst Estimates
The average one-year analyst price target for AVITA Medical was revised up 10.81% to $13.94 per share from $12.58, the prior estimate dated October 20, 2026. The figures are aggregate analyst targets collected by Fintel; the article provides no company results or market reaction.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly positive
Sentiment Score
0.20
Ticker Sentiment
RCEL0.30
More News
- Marvell Technology could plunge on latest multibillion-dollar acquisition
- UOB shares hit four-month low as Q3 profit misses analyst estimates
- Roku vp, cao Matthew Banks sells $86,906 in shares
- Palantir is dropping on earnings. Wall Street analysts remain bullish
- +49.6% since March: our AI-picked chipmaker keeps climbing after last week’s rout
- Sullivan: What the 2026 midterms could mean for energy investors